4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-17-029619
Chief Legal Officer sold 15,000 shares at $20.55 ($308,250)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dylan-Hyde Tyler Chief Legal Officer | 2017-12-22 | Sale | −15,000 | $20.55 | $308,250 | 115,204 | D: show line 1 in the form |
| Open-market sales · 15,000 sh · avg $20.55 · $308,250 | |||||||
Loading xslF345X03/doc4.xml…